These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23535840)

  • 1. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
    Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
    Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
    Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
    J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
    Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
    World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.
    Paruchuri V; Prasad A; McHugh K; Bhat HK; Polyak K; Ganju RK
    PLoS One; 2008 Mar; 3(3):e1741. PubMed ID: 18320059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
    Wang J; Barnes RO; West NR; Olson M; Chu JE; Watson PH
    Breast Cancer Res; 2008; 10(3):R51. PubMed ID: 18534028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
    Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
    Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
    Petersson S; Bylander A; Yhr M; Enerbäck C
    BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells.
    Adams BD; Cowee DM; White BA
    Mol Endocrinol; 2009 Aug; 23(8):1215-30. PubMed ID: 19423651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
    Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
    Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A7 (psoriasin) influences immune response genes in human breast cancer.
    Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
    Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells.
    Hsieh CY; Tsai PC; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2013 Feb; 27(1):1-10. PubMed ID: 23064031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
    Azios NG; Krishnamoorthy L; Harris M; Cubano LA; Cammer M; Dharmawardhane SF
    Neoplasia; 2007 Feb; 9(2):147-58. PubMed ID: 17356711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
    Marchesin V; Montagnac G; Chavrier P
    PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A putative role for psoriasin in breast tumor progression.
    Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
    Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.